Clinical Trial Update: Guanfacine Extended Release and Mindfulness Skills Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial of guanfacine extended release with mindfulness skills therapy was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stress Disorder

Drugs mentioned

• Guanfacine Extended Release (guanfacine)

Snippet

Sponsor: UConn Health | Conditions: Stress Disorder | Phase 4 | Status: WITHDRAWN